Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

被引:159
作者
Nelp, Micah T. [1 ]
Kates, Patrick A. [1 ]
Hunt, John T. [2 ]
Newitt, John A. [3 ]
Balog, Aaron [4 ]
Maley, Derrick [2 ]
Zhu, Xiao [3 ]
Abell, Lynn [5 ]
Allentoff, Alban [6 ]
Borzilleri, Robert [4 ]
Lewis, Hal A. [3 ]
Lin, Zeyu [5 ]
Seitz, Steven P. [4 ]
Yan, Chunhong [3 ]
Groves, John T. [1 ]
机构
[1] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[2] Bristol Myers Squibb Co, Immunooncol Biol, Princeton, NJ 08543 USA
[3] Bristol Myers Squibb Co, Mol Discovery Technol, Princeton, NJ 08543 USA
[4] Bristol Myers Squibb Co, Dept Discovery Chem, Princeton, NJ 08543 USA
[5] Bristol Myers Squibb Co, Leads Discovery & Optimizat, Princeton, NJ 08543 USA
[6] Bristol Myers Squibb Co, Dept Radiochem, Princeton, NJ 08543 USA
关键词
IDO1; heme; cancer; kynurenine; SOLUBLE GUANYLYL CYCLASE; 1; IDO1; INHIBITORS; TRYPTOPHAN CATABOLISM; CELL-PROLIFERATION; HEME; MECHANISM; INFLAMMATION; DIOXYGENASE; DISCOVERY; BINDING;
D O I
10.1073/pnas.1719190115
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
For cancer cells to survive and proliferate, they must escape normal immune destruction. One mechanism by which this is accomplished is through immune suppression effected by up-regulation of indoleamine 2,3-dioxygenase (IDO1), a heme enzyme that catalyzes the oxidation of tryptophan to N-formylkynurenine. On deformylation, kynurenine and downstream metabolites suppress T cell function. The importance of this immunosuppressive mechanism has spurred intense interest in the development of clinical IDO1 inhibitors. Herein, we describe the mechanism by which a class of compounds effectively and specifically inhibits IDO1 by targeting its apoform. We show that the in vitro kinetics of inhibition coincide with an unusually high rate of intrinsic enzyme-heme dissociation, especially in the ferric form. X-ray crystal structures of the inhibitor-enzyme complexes show that heme is displaced from the enzyme and blocked from rebinding by these compounds. The results reveal that apo-IDO1 serves as a unique target for inhibition and that heme lability plays an important role in posttranslational regulation.
引用
收藏
页码:3249 / 3254
页数:6
相关论文
共 52 条
[1]   Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications [J].
Alvarez, Lucia ;
Lewis-Ballester, Ariel ;
Roitberg, Adrian ;
Estrin, Dario A. ;
Yeh, Syun-Ru ;
Marti, Marcelo A. ;
Capece, Luciana .
BIOCHEMISTRY, 2016, 55 (19) :2785-2793
[2]  
[Anonymous], [No title captured], Patent No. [W02016/073774, 2016073774]
[3]  
Balog J. A., 2014, Patent, Patent No. [WO2014/150677, 2014150677]
[4]   Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase [J].
Basran, Jaswir ;
Booth, Elizabeth S. ;
Lee, Michael ;
Handa, Sandeep ;
Raven, Emma L. .
BIOCHEMISTRY, 2016, 55 (49) :6743-6750
[5]   The Mechanism of Formation of N-Formylkynurenine by Heme Dioxygenases [J].
Basran, Jaswir ;
Efimov, Igor ;
Chauhan, Nishma ;
Thackray, Sarah J. ;
Krupa, James L. ;
Eaton, Graham ;
Griffith, Gerry A. ;
Mowat, Christopher G. ;
Handa, Sandeep ;
Raven, Emma Lloyd .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (40) :16251-16257
[6]   Substrate Oxidation by Indoleamine 2,3-Dioxygenase EVIDENCE FOR A COMMON REACTION MECHANISM [J].
Booth, Elizabeth S. ;
Basran, Jaswir ;
Lee, Michael ;
Handa, Sandeep ;
Raven, Emma L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (52) :30924-30930
[7]   Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indo1-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate [J].
Crosignani, Stefano ;
Bingham, Patrick ;
Bottemanne, Pauline ;
Cannelle, Helene ;
Cauwenberghs, Sandra ;
Cordonnier, Marie ;
Dalvie, Deepak ;
Deroose, Frederik ;
Feng, Jun Li ;
Gomes, Bruno ;
Greasley, Samantha ;
Kaiser, Stephen E. ;
Kraus, Manfred ;
Negrerie, Michel ;
Maegley, Karen ;
Miller, Nichol ;
Murray, Brion W. ;
Schneider, Manfred ;
Soloweij, James ;
Stewart, Albert E. ;
Tumang, Joseph ;
Torti, Vince R. ;
Van den Eynde, Benoit ;
Wythes, Martin .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) :9617-9629
[8]   The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology [J].
Curti, Antonio ;
Trabanelli, Sara ;
Salvestrini, Valentina ;
Baccarani, Michele ;
Lemoli, Roberto M. .
BLOOD, 2009, 113 (11) :2394-2401
[9]   Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase [J].
Däubener, W ;
Spors, B ;
Hucke, C ;
Adam, R ;
Stins, M ;
Kim, KS ;
Schroten, H .
INFECTION AND IMMUNITY, 2001, 69 (10) :6527-6531
[10]   The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase [J].
Efimov, Igor ;
Basran, Jaswir ;
Sun, Xiao ;
Chauhan, Nishma ;
Chapman, Stephen K. ;
Mowat, Christopher G. ;
Raven, Emma Lloyd .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (06) :3034-3041